Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Research Award: PA -General Pandemic Prepared./Health Emergen. Research

McMaster University

$120,000.00

Investigating TNF Inhibition as a Therapeutic Strategy to Reduce Risk of Post-Pneumonia Cognitive Impairments in Older Adults

EF 2024-25

Résumé
Older adults are more susceptible to lung infections, such as pneumonia. They are also more likely to develop long-term health complications after infection that affect their brain health. The weakened brain health results in the loss of memory and problem-solving skills, known as cognitive decline. Cognitive decline in this population poses a significant burden to older adults and their caregivers, as it can result in loss of independence and lower quality of life. Yet, the biological mechanisms connecting pneumonia and brain health remain poorly understood, leaving us without effective treatments. We know that during infection, the immune system response causes inflammation, which activates brain cells called microglia. These cells typically maintain connections between neurons, but in older adults, unresolved brain inflammation may disrupt their function, leading to cognitive impairments. My PhD project aims to identify how inflammation from pneumonia affects microglial function in the brain. I will determine how pneumonia affects the number and function of microglia and changes in cognition. One focus will be tumor necrosis factor (TNF), a key protein factor that promotes inflammation. By using TNF-blocking drugs, we will assess whether we can reduce the risk of cognitive decline after pneumonia. Additionally, since men and women recover from pneumonia differently, we will investigate how sex influences the progression of cognitive decline post-infection. Findings in this study may also support research on other lung infections, such as influenza or COVID-19, providing new avenues for preventing long-term cognitive impairment in older adults. This research could significantly improve the quality of life for many older Canadians by identifying treatments that reduce the risk of post-infection cognitive decline.
Programme
Doctoral Research Award: PA -General Pandemic Prepared./Health Emergen. Research
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
519361
Name
Ermolina Sofya
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Aging
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Investigating TNF Inhibition as a Therapeutic Strategy to Reduce Risk of Post-Pneumonia Cognitive Impairments in Older Adults
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: PA -General Pandemic Prepared./Health Emergen. Research
Keyworddelim
Aging; Cognition; Dementia; Immunology; Infection; Inflammation; Microglia; Neurobiology; Respiratory Health; Tnf
Abstract
Older adults are more susceptible to lung infections, such as pneumonia. They are also more likely to develop long-term health complications after infection that affect their brain health. The weakened brain health results in the loss of memory and problem-solving skills, known as cognitive decline. Cognitive decline in this population poses a significant burden to older adults and their caregivers, as it can result in loss of independence and lower quality of life. Yet, the biological mechanisms connecting pneumonia and brain health remain poorly understood, leaving us without effective treatments. We know that during infection, the immune system response causes inflammation, which activates brain cells called microglia. These cells typically maintain connections between neurons, but in older adults, unresolved brain inflammation may disrupt their function, leading to cognitive impairments. My PhD project aims to identify how inflammation from pneumonia affects microglial function in the brain. I will determine how pneumonia affects the number and function of microglia and changes in cognition. One focus will be tumor necrosis factor (TNF), a key protein factor that promotes inflammation. By using TNF-blocking drugs, we will assess whether we can reduce the risk of cognitive decline after pneumonia. Additionally, since men and women recover from pneumonia differently, we will investigate how sex influences the progression of cognitive decline post-infection. Findings in this study may also support research on other lung infections, such as influenza or COVID-19, providing new avenues for preventing long-term cognitive impairment in older adults. This research could significantly improve the quality of life for many older Canadians by identifying treatments that reduce the risk of post-infection cognitive decline.
Competitiondate
202410
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Ermolina, Sofya
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~